Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prediman K Shah

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Reviews in Cardiovascular Medicine|March 15, 2006
Thrombogenic risk factors for atherothrombosisPrediman K Shah
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
ApoA-I Milano/phospholipid complexes emerging pharmacological strategies and medications for the prevention of atherosclerotic plaque progressionSanjay Kaul, Prediman K Shah
F1000Research|August 27, 2019
Inflammation in atherosclerotic cardiovascular diseasePrediman K Shah, Dalgisio Lecis
Current Atherosclerosis Reports|August 4, 2011
The SHAPE guideline: ahead of its time or just in time?Erling Falk, Prediman K Shah
Atherosclerosis|August 31, 2021
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigensJan Nilsson, Prediman K Shah
Frontiers in Pharmacology|September 22, 2015
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisKuang-Yuh Chyu, Prediman K Shah
Arteriosclerosis, Thrombosis, and Vascular Biology|April 20, 2007
Choking off plaque neovascularity: a promising atheroprotective strategy or a double-edged sword?Kuang-Yuh Chyu, Prediman K Shah
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Can we vaccinate against atherosclerosis?Kuang-Yuh Chyu, Prediman K Shah
Journal of the American College of Cardiology|May 30, 2020
Declining Admissions for Acute Cardiovascular Illness: The COVID-19 ParadoxJoseph E Ebinger, Prediman K Shah
Reviews in Cardiovascular Medicine|November 20, 2002
New strategies in managing and preventing atherosclerosis: focus on HDLMatthew J Price, Prediman K Shah
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Reviews in Cardiovascular Medicine|March 15, 2006
Thrombogenic risk factors for atherothrombosisPrediman K Shah
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
ApoA-I Milano/phospholipid complexes emerging pharmacological strategies and medications for the prevention of atherosclerotic plaque progressionSanjay Kaul, Prediman K Shah
F1000Research|August 27, 2019
Inflammation in atherosclerotic cardiovascular diseasePrediman K Shah, Dalgisio Lecis
Current Atherosclerosis Reports|August 4, 2011
The SHAPE guideline: ahead of its time or just in time?Erling Falk, Prediman K Shah
Atherosclerosis|August 31, 2021
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigensJan Nilsson, Prediman K Shah
Frontiers in Pharmacology|September 22, 2015
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisKuang-Yuh Chyu, Prediman K Shah
Arteriosclerosis, Thrombosis, and Vascular Biology|April 20, 2007
Choking off plaque neovascularity: a promising atheroprotective strategy or a double-edged sword?Kuang-Yuh Chyu, Prediman K Shah
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Can we vaccinate against atherosclerosis?Kuang-Yuh Chyu, Prediman K Shah
Journal of the American College of Cardiology|May 30, 2020
Declining Admissions for Acute Cardiovascular Illness: The COVID-19 ParadoxJoseph E Ebinger, Prediman K Shah
Reviews in Cardiovascular Medicine|November 20, 2002
New strategies in managing and preventing atherosclerosis: focus on HDLMatthew J Price, Prediman K Shah
Pageof 25